Ex-Genzyme head's startup plans first drug trial after $80M round
September 28, 2018 at 11:32 AM EDT
KSQ Therapeutics is developing drugs using a database of genes from more than 600 types of cancer.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.